Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Melanoma 35Lung Neoplasms 12Neoplasm Metastasis 10Carcinoma, Renal Cell 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Cutaneous 6Breast Neoplasms 6Brain Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Merkel Cell 5Carcinoma, Hepatocellular 5Uveal Melanoma 4Thyroid Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Mycosis Fungoides 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Carcinoma, Basal Cell 4Waldenstrom Macroglobulinemia 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, T-Cell 3

Interventions

fludarabine phosphate 1fludarabine 1aldesleukin 1Spinal Puncture 1Specimen Handling 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Magnetic Resonance Spectroscopy × Dermatologic × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡